()-[1-(cis),3α,4β]-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid monohydrochloride structure
|
Common Name | ()-[1-(cis),3α,4β]-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid monohydrochloride | ||
|---|---|---|---|---|
| CAS Number | 79516-67-9 | Molecular Weight | 456.980 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C26H30ClFN2O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | R50547 |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C26H30ClFN2O2 |
|---|---|
| Molecular Weight | 456.980 |
| Exact Mass | 456.197998 |
| 4-Piperidinecarboxylic acid, 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-, (3S,4R)-, hydrochloride (1:1) |
| Levocabastine hydrochloride |
| (3S,4R)-1-(cis-4-Cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-4-piperidinecarboxylic acid monohydrochloride |
| acide (3S,4R)-1-[cis-4-cyano-4-(4-fluorophényl)cyclohexyl]-3-méthyl-4-phénylpipéridine-4-carboxylique chlorhydrate |
| Levocabastine for system suitability 2 |
| Levostin |
| R50547 |
| (3S,4R)-1-[cis-4-Cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-4-piperidinecarboxylic acid hydrochloride (1:1) |
| [3S-[1(cis),3α,4β]]-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-4-piperidinecarboxylic acid |
| Levophta |
| (3S,4R)-1-[cis-4-Cyan-4-(4-fluorphenyl)cyclohexyl]-3-methyl-4-phenylpiperidin-4-carbonsäurehydrochlorid |
| (3S,4R)-1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid hydrochloride |
| 4-piperidinecarboxylic acid, 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-, (3S,4R)-, monohydrochloride |
| MFCD07787408 |
| (3S,4R)-1-[cis-4-Cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid hydrochloride (1:1) |
| Levocabastine (hydrochloride) |